Characteristics of the 313 patients
| Characteristic . | Category . | N . | % . |
|---|---|---|---|
| Patient characteristics | |||
| Age | > 45 | 73 | 23 |
| Sex | Male | 180 | 58 |
| Prognostic parameters | |||
| VS | > 30 | 189 | 62 |
| VS | > 50 | 131 | 43 |
| B symptoms | Yes | 143 | 46 |
| Albumin | < 40 | 129 | 45 |
| Hemoglobin | < 10.5 | 44 | 14 |
| Lymphocytes | < 8 | 45 | 15 |
| GB | ≥ 15 | 66 | 21 |
| Ann Arbor stage | I-II | 228 | 74 |
| Ann Arbor stage | IV | 42 | 14 |
| IPS (Hasenclever score) | |||
| 0 | 39 | 14 | |
| 1 | 90 | 32 | |
| 2 | 70 | 25 | |
| 3 | 44 | 16 | |
| 4 | 27 | 10 | |
| >5 | 13 | 5 | |
| Treatment | |||
| EBVP | 68 | 22 | |
| ABVD | 208 | 66 | |
| BEACOPP | 37 | 12 |
| Characteristic . | Category . | N . | % . |
|---|---|---|---|
| Patient characteristics | |||
| Age | > 45 | 73 | 23 |
| Sex | Male | 180 | 58 |
| Prognostic parameters | |||
| VS | > 30 | 189 | 62 |
| VS | > 50 | 131 | 43 |
| B symptoms | Yes | 143 | 46 |
| Albumin | < 40 | 129 | 45 |
| Hemoglobin | < 10.5 | 44 | 14 |
| Lymphocytes | < 8 | 45 | 15 |
| GB | ≥ 15 | 66 | 21 |
| Ann Arbor stage | I-II | 228 | 74 |
| Ann Arbor stage | IV | 42 | 14 |
| IPS (Hasenclever score) | |||
| 0 | 39 | 14 | |
| 1 | 90 | 32 | |
| 2 | 70 | 25 | |
| 3 | 44 | 16 | |
| 4 | 27 | 10 | |
| >5 | 13 | 5 | |
| Treatment | |||
| EBVP | 68 | 22 | |
| ABVD | 208 | 66 | |
| BEACOPP | 37 | 12 |
N (%) correspond to patients in the poor prognosis group. The IPS score was not estimated in 30 patients with missing data in any component of the score.
VS indicates erythrocyte sedimentation rate; and GB, leukocyte.